# 24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension

> **NCT01655758** · PHASE4 · COMPLETED · sponsor: **University of Parma** · enrollment: 61 (actual)

## Conditions studied

- Ocular Hypertension

## Interventions

- **DRUG:** 0.5% timolol
- **DRUG:** timolol-dorzolamide fixed combination
- **DRUG:** Latanoprost
- **DRUG:** Travoprost
- **DRUG:** Bimatoprost

## Key facts

- **NCT ID:** NCT01655758
- **Lead sponsor:** University of Parma
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2003-12
- **Final completion:** 2004-02
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2012-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01655758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01655758, "24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01655758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*